Statistics
Publications
58
Citations
4.2K
H-Index
33
Active since
1992
Yuan Li Shen is an author at United States Food and Drug Administration specializing in medicine, oncology, and pharmacology.
Publications per year
1992–2024
58
58
FDA Drug Approval Summary: Bevacizumab (Avastin®) as Treatment of Recurrent Glioblastoma Multiforme
Martin H. Cohen, Yuan Li Shen, Patricia Keegan et al. · The Oncologist · 2009 · 648 citations · Full text
Medicine, Oncology, Pharmacology +12
1–5 of 58